A novel RLN1-RLN2 fusion was observed in LNCaP cells and normal and prostate cancer tissues.
The fusion putatively encodes a RLN2 isoform with a deleted secretory signal peptide.
RLN1 is underrepresented in PCa cell lines.
Androgens inversely regulate RLN1 and the RLN1-RLN2 fusion transcript.